The number of cases of liver cancer could rise by 76% by 2050 to 1.52 million, according to an analysis in The Lancet.

A panel of specialists in China has estimated a 76% increase in cases of hepatocellular carcinoma, from 0.87 million in 2022 to 1.52 million in 2050. The survival rate for this type of cancer is between 5% and 30%. Annual deaths could also increase by 81%, from 0.76 million to 1.37 million. Most cases are preventable, with 60% caused by risk factors such as fatty liver disease and hepatitis B and C virus infections.